Co-Highly Expressed SLC17A9 and KCNH1 as Potential Prognostic Biomarkers and Therapeutic Targets in Clear Cell Renal Cell Carcinoma
Background: The vesicular nucleotide transporter Solute Carrier Family 17 Member 9 (SLC17A9) has recently been recognized as a significant modulator of oncogenic pathways, with its elevated expression levels being closely linked to the aggressiveness of clear cell renal cell carci...
Saved in:
| Main Authors: | Zongpan Ke, Zhiwang Tang, Deyun Shen, Yixun Liu, Yawei Shu, Xiangyu Mu, Zexuan Li, Ping Xiang, Bing Zhong, Xuechun Hu, Ruoyun Tan, Jun Xiao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2025-04-01
|
| Series: | Frontiers in Bioscience-Landmark |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/FBL/30/4/10.31083/FBL38061 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knock-in Kcnh2 rabbit model of long QT syndrome type-2, epilepsy, and sudden death
by: Veronica Singh, et al.
Published: (2025-04-01) -
Neonatal death of siblings with Uhl’s disease and KCNH2 mutation - A rare association
by: Francesco Ventura, et al.
Published: (2024-11-01) -
Congenital long QT syndrome caused by a KCNH2 pathogenic variant exhibiting “motor seizures”: a case report and literature review
by: Mei Jin, et al.
Published: (2025-03-01) -
Pathogenic KCNH2-G53S variant in the PAS domain influences the electrophysiological phenotype in long QT syndrome type 2
by: Dasom Mun, et al.
Published: (2025-04-01) -
Lack of significant ganglioside changes in Slc17a5 heterozygous mice: Relevance to FSASD and Parkinson's disease
by: Marya S. Sabir, et al.
Published: (2025-06-01)